-
1 Comment
Shin Nippon Biomedical Laboratories, Ltd is currently in a long term uptrend where the price is trading 42.5% above its 200 day moving average.
From a valuation standpoint, the stock is 97.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Shin Nippon Biomedical Laboratories, Ltd's total revenue sank by 7.2% to $3B since the same quarter in the previous year.
Its net income has dropped by 53.7% to $337M since the same quarter in the previous year.
Based on the above factors, Shin Nippon Biomedical Laboratories, Ltd gets an overall score of 2/5.
| Exchange | TSE |
|---|---|
| ISIN | JP3379950003 |
| CurrencyCode | JPY |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | 54B |
|---|---|
| Beta | -0.23 |
| PE Ratio | 10.91 |
| Target Price | 2840 |
| Dividend Yield | 3.9% |
Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies. The company also engages in the investigator brochure preparation support, clinical trial protocol creation support, clinical trial medical institution, investigational drug allocation, clinical trial request/contract, monitoring, quality management, data management, statistical analysis work, comprehensive report creation support, electronic application support, regulatory affairs consulting, and creating informed consent documents support services. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of vaccines and therapeutic drugs, antibody drugs, nucleic acid drugs, peptide drugs, gene therapy, and regenerative medicines. Further, the company is involved in the operates geothermal power generation; operates hotel accommodation facilities; and wellbeing businesses, as well as provides cleaning, clerical work, and welfare services. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2395.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
